Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In addition the AEs are less or equal to the current gold standard!
What's the practical day to day implication?
I understand what PP means about getting an informal endorsement from the fda with BTD but at the end of the day it's about getting the drug to market and I would love to have BTD I think fast track is a huge benefit.
Agreed but fast track is nothing to sneeze at. It certainly allows us to move through the process much faster than usual.
PP if we are developing B-OM under fast track designation how does btd change the process? I guess I am still confused about the difference.
Gap the open again! Just manipulation pure and simple.
His email is on the company website. Do it yourself!
Fake news from a dishonest non-shareholder
Gap the open! Love that manipulation
I disagree. He wants to stir up discontent...pure and simple.
It's sad that out of the blue a poster rehashes an old discredited story!
Exactly! Where else is the money coming from.
Moving K forward along with our ant-inflammatory drugs is brilliant. Oncology and anti-inflammatory drugs are very desirable.
Yes the old gap the open trap! How many times have we seen that one before?
It was a very smart and savvy decision to not go after 1 expensive phase 3 trial but to use funds to demonstrate the anti-inflammatory properties!
Exactly I am not sure what's so hard to understand.
Planning for a phase 3 and executing a phase 3 without a partner are 2 different things. Phase 3 trials are long and expensive. We have never had enough capitol for a phase 3 as well as our other trials.
It's called non-revenue biotech. It's not complicated. The plan has always to partner before phase 3.
No you are wrong again.
Lmao! You are working over time to insist that most of trials have been failures! Good one!
Try looking at the trials!
The company will have up front payments in the bank helping to cover cash flow needs. You need to understand that a percentage of the payment if you will is because we have the drug and they don't. That's part of the risk the BP takes.
I would imagine that getting additional financing would be much easier with say $50m in the bank paying overhead costs.
Can you give us link or name of blog
I agree completely! Obviously there are 2 sides to this situation.
I suggest anyone confused or concerned with his choice of words should break out their dictionary!
I agree! Good news for ipix! The short term financing question has been resolved. It's unfortunate that those opposed to ipix are working hard to convince others that this is a bad deal but I would expect nothing less!
and if this worthless why this is so much attention on board, 15,737 reads so far today on ihub Brillant! Question of the day/year!
Yes! Please sell and save yourself all the time and trouble.
Phony is a great and descriptive word for him.
Check level 4 out again.
But he is still on the board LOL! Check level 4!
Since they aren't running any current trials they only need a core group.
I agree Dr. B is more than capable to finish any needed work on the drugs.
Why dont you check the level 4 again.
Please go back and check the article against your L4! I am sure you will give some great info
Dont let anyone pull your chain...there is no level 4 stock data! Lmao!
Again your expertise is appreciated? Lots of bs on this board.